Ultragenyx Pharmaceutical, Inc. (RARE)
22.75
+0.24
(+1.07%)
USD |
NASDAQ |
Feb 24, 16:00
22.70
-0.05
(-0.22%)
Pre-Market: 08:11
Ultragenyx Pharmaceutical Market Cap : 2.195B for Feb. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 3.837B |
| Johnson & Johnson | 593.51B |
| CorMedix, Inc. | 557.04M |
| Insmed, Inc. | 33.83B |
| Regeneron Pharmaceuticals, Inc. | 81.64B |
Market Cap Related Metrics
| PS Ratio | 3.335 |
| Price | 22.75 |
| Earnings Yield | -25.65% |